
In the interim results, MICROPORT NEU reported a net profit of RMB 92.92 million, a decrease of 35%, and declared a dividend of 5 Hong Kong cents
MicroPort Neuro (02172.HK) announced its interim results for the six months ending in June, with revenue of RMB 383 million, a year-on-year decrease of 6.2%; gross profit of RMB 281 million, down 4.7%. It recorded a net profit of RMB 92.92 million, a decline of 35.2%, with earnings per share of 16 cents. An interim dividend of HKD 0.05 was declared, compared to HKD 0.08 in the same period last year.
In the first half of the year, affected by the centralized procurement policy, revenue from hemorrhagic stroke products decreased by 5.5% to RMB 234 million; coupled with the cessation of cooperation on previously represented products, revenue from carotid artery atherosclerosis products was RMB 115 million, down 11.5%
